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The aim of this study was to evaluate the effects of supervised treadmill-walking training on 
the calf muscle capillarization in patients with intermittent claudication. The first 12-week 
period was a non-exercise, within-subject control stage and the second 12-week period was 
an exercise training stage. Calf muscle biopsy samples were obtained at baseline, pre- and 
post-exercise training. Functional capacities were measured after each biopsy. Eleven 
subjects completed all procedures. Their average age was (mean ± SD) 73.9 ± 5.5 years, 
resting ankle-to-brachial index (ABI) 0.57 ± 0.11 and post-exercise ABI 0.40 ± 0.14 at 
baseline. After exercise training, there was no significant change in calf muscle 
capillarization, though walking capacity and peak oxygen uptake were increased 
significantly. The difference between the pre- and post-training capillaries in contact with 
type IIx and IIa muscle fibers for each subject was significantly correlated with an improved 
pain-free walking time, r=0.69 and r=0.62 (both p<0.05), respectively. This finding suggests 
that the change in calf muscle capillarization might contribute to improved walking capacity 
following exercise training in subjects with intermittent claudication.  
 
Introduction 
Peripheral arterial disease (PAD) is one of the major atherosclerotic diseases with stenosis 
and occlusion of the peripheral arteries, mostly in the lower limb.1,2 The characteristic 
complaint of PAD is intermittent claudication (IC), a severe muscular pain in the leg in 
response to walking a reproducible distance.3,4 IC seriously limits walking capacity of the 
patients. Supervised treadmill-walking training has been demonstrated as an effective 
treatment for patients with IC. The training benefits the patients by improving walking 
capacity, delaying occurrence of claudication and increasing tolerance to pain.5-8 Research 
has examined whether the improved walking capacity was related to the changes in skeletal 
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muscle histology,9 muscular enzyme activities,9 walking economy,6,10 and muscle strength or 
endurance.7,11 However, the exact mechanism for the beneficial effects is still unclear.    
Walking induced claudication has been speculated to be a result of an inadequacy of regional 
blood flow to meet metabolic demands of the leg muscles.2,3 It can be hypothesized that an 
improved blood supply to the muscles would be one of the mechanisms for the delayed onset 
of claudication and improved walking capacity after exercise. Previous studies have 
measured blood flow5,6,12-14 and systolic blood pressure5-7,12,14-16 in the leg in patients with IC. 
However no conclusive evidence has been obtained with respect to the changes in blood 
circulation after exercise training. Another potential mechanism for the improved walking 
capacity is the capillarization in the muscle. A review of muscle blood flow and aerobic 
capacity in healthy older people has demonstrated that the increase in muscle capillarization 
after endurance training would enhance oxygen and nutrient exchanges within the tissue by 
providing a larger surface area and shorter diffusion distance.17 To the best of our knowledge, 
there has been no study that has examined calf muscle capillarization in adaptation to 
supervised treadmill-walking training in patients with IC. In the present study, we aimed to 
evaluate the effect of 12 weeks of supervised treadmill-walking training on muscle 
capillarization and the relationship between the changes in walking capacity and muscle 
capillarization in subjects with IC.  
Methods 
Design 
An original purpose of the study was to evaluate whether exercise training combined with a 
treatment of ginkgo biloba (a natural herbal) would produce better results in improving 
walking capacity and other physiological variables than exercise training plus placebo. The 
study was designed with two 12-week stages. Subjects were randomly allocated into a ginkgo 
group or a placebo group by a third-party. During the first stage, subjects took either ginkgo 
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or placebo tablets in a double-blinded manner and were instructed to make no major changes 
in their diet and exercise habits. During the second stage, all subjects participated in a 
supervised treadmill-walking program while continued with the ginkgo or placebo treatment. 
Functional tests and muscle biopsy for histochemical analysis of muscle fiber types and 
capillarization were performed at the baseline, and the end of each 12-week stage. The 
performance tests detected no significant changes in the measured variables between the 
combined treatment and exercise training plus placebo.18 Therefore, the data of the two 
groups were collapsed to evaluate the effects of exercise training on the measured variables. 
The first stage was defined as the control stage and the second stage as the training stage. The 
focus of this paper was to examine the effect of the 12-week supervised treadmill-walking 
training on calf muscle capillarization in subjects with IC and the correlations between the 
potential changes in walking capacity, peak oxygen uptake (peak O2), ankle-to-brachial 
systolic blood pressure index (ABI), and calf muscle capillarization after exercise training.   
Subjects 
Volunteer subjects were recruited from the local population in the Northern Rivers region of 
New South Wales, Australia. The inclusion criteria were 1) 50-80 years of age; 2) resting 
ABI was lower than 0.9 and decreased to lower than 0.8 after a treadmill-walking test; and 3) 
a stable history of IC for at least six months at the initial interview. The exclusion criteria 
were 1) resting ischemic pain, ulceration, or gangrene in the legs; 2) inability to walk on the 
treadmill at a speed of 3.2 km/h; and 3) exercise capacity limited by symptoms of angina, 
congestive heart failure, chronic obstructive pulmonary disease, or arthritis. This study was 
approved by the Human Research Ethics Committee of Southern Cross University, Australia. 
Written informed consent was obtained from each subject before the baseline test.  
Functional measurements  
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A graded treadmill test was used to determine walking capacity.19 The time to the onset of 
claudication was recorded as the pain-free walking time (PFWT) and the time until exercise 
was ceased due to maximal claudication was recorded as the maximal walking time (MWT). 
A 5-point scale was applied to identify the intensity of pain,7 in which 1 = no pain; 2 = onset 
of claudication; 3 = mild pain; 4 = moderate pain; 5 = maximal claudication. Peak O2 was 
assessed during the treadmill test using a MedGraphics CPX/D System (Medical Graphics 
Corporation, USA) and was defined as the average of the two highest and connected 15-
second O2 achieved during the test.20 
Peripheral hemodynamics  
A bi-directional Doppler unit MD5 (Hokanson, USA) was used to measure blood pressures. 
The ABI was calculated as the systolic pressure at the posterior tibial or dorsalis pedis 
arteries (the higher data was used) divided by that at the brachial artery. Resting and post-
exercise ABI (within two minutes after the treadmill test) were measured in both legs. All 
measurements were performed by the same researcher.  
Muscle biopsy 
Needle muscle biopsies were taken from the medial head of the gastrocnemius muscle in the 
worse leg (with lower ABI). Type I, IIa, and IIx fibers were classified by staining of myosin 
ATPase isoforms.21 An average of 230 muscle fibers (range 120-500) was identified in each 
sample. The Amylase-Periodic Acid Schiff (PAS) method was used to visualize capillaries in 
muscle tissue.22 An average of 370 capillaries (range 210-700) was identified in each sample. 
The number of capillaries around the muscle fibers (up to 50 randomly selected fibers for 
each type) was assessed. The capillarization was expressed as capillary-to-fiber ratio (C/F; 
total number of capillaries divided by total muscle fibers in the investigated area) and the 
number of capillaries in contact with each different type of muscle fibers (CC). The 
calculation of CC followed Plyley’s method.23 
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Supervised treadmill-walking program  
Subjects trained in the laboratory one hour per session, three sessions per week, for 12 weeks 
following an individualized exercise program. They started walking on a treadmill at the 
speed of 3.2 km/h with an individualized incline. This combination of speed and incline 
elicited a moderate claudication (level 4 on the 5- point scale) after about five minutes of 
walking. When they felt moderate claudication in their legs, subjects were allowed to recover 
in a sitting position and resumed walking when the pain disappeared. When the subject could 
walk seven minutes without moderate claudication, treadmill incline was increased by 0.5% 
each time. When the incline had been increased as high as 5%, the speed was then increased 
0.5km/h each time for further increase of exercise intensity. This progressive procedure 
aimed to continuously provide overloading while the walking capacity of the subject was 
improving. All training sessions were supervised by the researcher and ECG (modified lead II 
configuration) was monitored to ensure subjects’ safety when exercise intensity was 
increased. 
Statistical analysis 
Analysis of variance (ANOVA) with repeated measures was performed to detect the overall 
effect of the treatment among the baseline, 12-week and 24-week tests for PFWT, MWT, 
peak O2, ABI, muscle fiber type distribution and capillarization. Post-hoc analysis with 
Bonferroni adjustment was applied to reveal where a significant difference presented if there 
was a significant overall effect. Pearson product moment correlation coefficient was 
calculated to assess the relationships between changes in the measured variables following 
exercise training. All variables were presented as means ± SD. An alpha level of 0.05 was set 
for significant difference. All statistical analyses were performed using the SPSS statistical 
software package (SPSS Version 14.0 for Windows, SPSS Inc.). 
Results 
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Seventeen subjects completed the 24-week program. Six of them who had only one or two 
muscle biopsies were not included in this paper: four of them missed the second biopsy for 
their personal reasons. Another two took the first two biopsies but refused the third one. 
Therefore 11 subjects volunteered for all three muscle biopsies and their data was analyzed 
and reported in this paper. The average age of this group was 73.9 ± 5.5 years, with resting 
ABI 0.57 ± 0.11 and post-exercise ABI 0.40 ± 0.14 at baseline.  
The PFWT, MWT, and peak O2 did not change significantly during the control stage, but 
significantly increased after the training stage. Neither the resting nor the post-exercise ABI 
showed a significant change following exercise training (Table 1).  
There was no significant difference in the muscle fiber type composition over the three 
muscle biopsies. For this group of subjects, nearly half of the muscle fibers in the 
gastrocnemius muscle were type II fibers and more type IIx fibers than type IIa fibers (Table 
2). The C/F and CC with each type of muscle fiber were not significantly different between 
the three biopsies (Table 2).  
In the hypothesis generating analysis, the difference between the pre- and post-training CC 
with type IIx and IIa fibers for each subject was significantly correlated with an improved 
PFWT, r = 0.69 and r = 0.62 (both P<0.05), respectively. There were no significant 
correlations between the differences in CC with type I muscle fibers and C/F with the 
increase in PFWT following exercise training. The differences in CC with the three types of 
muscle fibers and C/F did not show significant correlations with the changes in MWT and 
peak O2 after the training.  
Discussion  
The present study did not find significant changes in the calf muscle capillarization in this 
group of subjects, though their walking capacity and peak O2 were increased significantly 
following 12 weeks of supervised treadmill-walking training. This result indicated that the 
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substantial improvement in walking capacity was not matched by substantial improvement in 
muscle capillarization. It is noteworthy, in the hypothesis generating analysis, that the 
changes in capillary supply to type II fibers in the calf muscles were significantly related to 
the increase in PFWT following training. It was found that approximately 50% of all muscle 
fibers in the calf muscles were Type II fibers in this group of subjects. Previous research in 
healthy older populations has reported that increased muscular capillarization can enhance 
oxygen and nutrient exchanges within the tissue17 and is positively associated with leg blood 
flow.24 Considering the increased PFWT following training in the present study, the 
correlations show that improved capillary supply to the calf muscles is likely to be a reason 
for the improvement in walking capacity.  
Studies on healthy older people have reported that endurance training can significantly 
increase capillary supply to skeletal muscles, which are associated with increased peak O2 25 
or metabolic enzyme activities.26 It has been reported that the increased capillarization 
provided a larger surface area for exchange of oxygen and other substance between the 
capillaries and muscle fibers.17,26 Our results appear d to be in agreement with that report. 
The ratio of capillaries to muscle fibers might affect oxygen and nutrient supply and delay the 
mismatch between supply and demand.  
The changes in calf muscle capillarization did not show significant correlation with the MWT 
after training. It has been reported that local perfusion is not the only factor controlling 
MWT.6 Other factors, such as pain tolerance, gait adaptation to treadmill walking, or 
psychological factor, might have contributed to the improved maximal walking capacity. 
Previous study indicated that peak O2 of patients with PAD is more likely to be limited by 
claudication and does not necessarily reflect the limit in metabolic function.27 Our results 
agreed with these statements and we did not find significant relationship between the 
increases in MWT and peak O2 of and the change in calf muscle capillarization. Resting or 
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post-exercise ABI did not show any significant changes following training. It has been 
suspected that ABI may not reflect blood flow to muscle tissue during walking and this may 
explain its weak relationship with walking performance.28 
The major limitation of this study might be the relatively small number of subjects, which did 
not provide enough statistical power to detect significant changes in muscle capillarization 
following exercise training. In addition, the exercise program employed in our study may not 
produce sufficient training stimulus to significant adaptation in the muscle tissues. It has been 
reported that resistance training significantly increased capillary density in the calf muscles of 
patients with IC.29 
Conclusion 
We observed that the 12-week supervised treadmill-walking training did not change calf 
muscle capillarization significantly, though the training resulted in a significant increase in 
walking capacity in this group of subjects. Significant correlations were found between the 
increase in PFWT and the changes in CC with type II muscle fibers. Even though with a 
small sample size, this result shows a trend in which the change in muscle capillarization may 
be a mechanism through which supervised treadmill-walking training effectively improved 
walking capacity in subjects with IC. In order to confirm this point of view, a larger 
experimental group and longer duration of exercise training may be needed in the future 
studies.  
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Table 1 Changes in walking capacity, peak oxygen uptake and ankle-to-brachial index 
(ABI) at the three tests 
Baseline 12-week 24-week
PFWT (s) 116 ± 65 130 ± 62 348 ± 264**
MWT (s) 308 ± 135 323 ± 161 714 ± 191***
Peak O2 (ml/kg/min) 12.93 ± 2.10 12.76 ± 2.35 14.90 ± 2.56*
Resting ABI 0.57 ± 0.11 0.60 ± 0.18 0.59 ± 0.15
Post-exercise ABI 0.40 ± 0.14 0.45 ± 0.29 0.41 ± 0.19
All data are presented as means ± SD
* p<0.05; ** p<0.01; *** p<0.001, the 12-week test vs. the 24-week test
PFWT: pain-free walking time; MWT: maximal walking time. 
































































Table 2 Changes in muscle fibre types and the number of capillaries in contact (CC) 
with each fibre at the three tests  
 Baseline  12-week 24-week 
Type I (%) 55.1 ± 16.5 55.4 ± 22.5 51.4 ± 12.9 
Type IIa (%) 19.3 ± 9.8 16.9 ± 7.8 18.2 ± 8.2 
Type IIx (%) 25.7 ± 18.9 27.6 ± 21.0 30.4 ± 15.9 
Capillary-to-fiber ratio  1.63 ± 0.33 1.70 ± 0.45 1.73 ± 0.32 
CC with type I 1.86 ± 0.29 1.95 ± 0.35 2.14 ± 0.36 
CC with type IIa 1.49 ± 0.34 1.53 ± 0.42 1.67 ± 0.19 
CC with type IIx 1.13 ± 0.27 1.17 ± 0.33 1.34 ± 0.31 
All data are presented as means ± SD 
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